Novartis AG Market Capitalization vs. Cash and Equivalents Fundamental Analysis
Novartis AG is regarded fifth in cash and equivalents category among related companies. It is regarded fifth in market capitalization category among related companies creating about 27.45 of Market Capitalization per Cash and Equivalents. Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
|Cash and Equivalents|
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.Novartis AG is regarded fifth in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Major industry is now estimated at about 1.49 Trillion. Novartis retains roughly 193.54 Billion in market capitalization claiming about 13% of equities under Drug Manufacturers - Major industry.
Novartis Fundamental Comparison